EGFR DEL19
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19) (NCT06053099) | Intergroupe Francophone de Cancerologie Thoracique | 2024-01-22 |
Track EGFR DEL19 automatically
Every clearance here is in the API, with alerts when new ones post.